{"id":7690,"date":"2024-09-24T17:57:25","date_gmt":"2024-09-24T22:57:25","guid":{"rendered":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/?p=7690"},"modified":"2024-09-24T17:57:29","modified_gmt":"2024-09-24T22:57:29","slug":"remdesivir-dexamethasone-tied-to-fewer-deaths-in-severe-covid","status":"publish","type":"post","link":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/2024\/09\/24\/remdesivir-dexamethasone-tied-to-fewer-deaths-in-severe-covid\/","title":{"rendered":"Remdesivir-Dexamethasone Tied to Fewer Deaths in Severe COVID"},"content":{"rendered":"<div class=\"panel body-content\"><div class=\"panel__container\">\n<p><a href=\"https:\/\/www.medpagetoday.com\/infectiousdisease\/covid19\/112093?xid=nl_mpt_DHE_2024-09-24&amp;mh=07f73d99b2b546c079b0b5a2312d87b1&amp;utm_source=Sailthru&amp;utm_medium=email&amp;utm_campaign=Daily%20Headlines%20Evening%202024-09-24&amp;utm_term=NL_Daily_DHE_dual-gmail-definition\">MedPage<\/a> Treatment with the antiviral remdesivir (Veklury) plus dexamethasone was linked to fewer deaths among patients hospitalized for COVID-19 compared with dexamethasone monotherapy, a retrospective study suggested.<\/p>\n\n\n\n<p>Using propensity score matching, the drug duo was associated with an overall 26% reduction in mortality at 14 days (adjusted HR 0.74, 95% CI 0.69-0.78,\u00a0<em>P<\/em>&lt;0.0001) and an overall 24% reduction at 28 days (aHR 0.76, 95% CI 0.72-0.81,\u00a0<em>P<\/em>&lt;0.0001) when compared with dexamethasone alone, reported Andre Kalil, MD, MPH, of the University of Nebraska Medical Center in Omaha, and colleagues in\u00a0<a href=\"https:\/\/academic.oup.com\/cid\/advance-article\/doi\/10.1093\/cid\/ciae477\/7762570\" target=\"_blank\" rel=\"noreferrer noopener\"><em>Clinical Infectious Diseases<\/em><\/a><\/p>\n\n\n\n<p><a href=\"http:\/\/Treatment with the antiviral remdesivir (Veklury) plus dexamethasone was linked to fewer deaths among patients hospitalized for COVID-19 compared with dexamethasone monotherapy, a retrospective study suggested.  Using propensity score matching, the drug duo was associated with an overall 26% reduction in mortality at 14 days (adjusted HR 0.74, 95% CI 0.69-0.78, P<0.0001) and an overall 24% reduction at 28 days (aHR 0.76, 95% CI 0.72-0.81, P<0.0001) when compared with dexamethasone alone, reported Andre Kalil, MD, MPH, of the University of Nebraska Medical Center in Omaha, and colleagues in Clinical Infectious Diseasesopens in a new tab or window.\">Continue reading<\/a><\/p>\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>MedPage Treatment with the antiviral remdesivir (Veklury) plus dexamethasone was linked to fewer deaths among patients hospitalized for COVID-19 compared with dexamethasone monotherapy, a retrospective study suggested. Using propensity score matching, the drug duo was associated with an overall 26% reduction in mortality at 14 days (adjusted HR 0.74, 95% CI 0.69-0.78,\u00a0P&lt;0.0001) and an overall [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[11],"tags":[],"class_list":["post-7690","post","type-post","status-publish","format-standard","hentry","category-covid"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/7690","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/comments?post=7690"}],"version-history":[{"count":1,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/7690\/revisions"}],"predecessor-version":[{"id":7691,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/7690\/revisions\/7691"}],"wp:attachment":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/media?parent=7690"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/categories?post=7690"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/tags?post=7690"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}